Senators Reverend Warnock, Shaheen Demand Answers from Novo Nordisk for Breaking Promise to People with Diabetes
April 18, 2024
April 18, 2024
WASHINGTON, April 18 -- Sen. Raphael G. Warnock, D-Georgia, issued the following news release:
The Senators demanded answers from Novo Nordisk on why the company discontinued the production of Levemir after taking a public relations victory lap for lowering the cost of Levemir and other insulin products
After announcing the discontinuation of Levemir, Novo Nordisk does not plan to offer a price discount on any alternative form of long-acting insulin, the most prescribed . . .
The Senators demanded answers from Novo Nordisk on why the company discontinued the production of Levemir after taking a public relations victory lap for lowering the cost of Levemir and other insulin products
After announcing the discontinuation of Levemir, Novo Nordisk does not plan to offer a price discount on any alternative form of long-acting insulin, the most prescribed . . .